Peter D. Crompton

National Institutes of Health

Papers

1

Total Citations

39

H-Index

1

About

Dr. Peter D. Crompton is a leading immunologist whose research focuses on the intricate host-pathogen interactions that define human malaria, particularly *Plasmodium falciparum* infection. His major contributions center on understanding naturally acquired immunity and the immunological mechanisms underlying vaccine efficacy. In a landmark 2014 study, Dr. Crompton and his team provided critical serologic evidence that the RTS,S malaria vaccine—the world’s first licensed malaria vaccine—reduces exposure to both liver- and blood-stage parasites. This work, which has garnered significant attention, helped explain why the vaccine offers only partial protection against clinical disease. By demonstrating that RTS,S vaccination is associated with decreased exposure to blood-stage parasites, his research has shaped the strategic use of this vaccine and informed the development of next-generation malaria interventions. Dr. Crompton’s work is foundational for researchers and students seeking to unravel the complex immune responses to malaria and to design more effective vaccines against this devastating disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
39
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to Plasmodium falciparum Liver- and Blood-Stage Parasites*
39 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago